Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
New York Med Coll
Valhalla, NY 10595
Education & Training
New York Medical CollegeClass of 2015
Certifications & Licensure
IL State Medical License 2021 - 2026
IN State Medical License 2023 - 2025
TX State Medical License 2018 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer Start of enrollment: 2021 Jun 01
Roles: Contact
- CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer Start of enrollment: 2022 Apr 20
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsIntegration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence.Frederick M Howard, James Dolezal, Sara Kochanny, Galina Khramtsova, Jasmine Vickery
NPJ Breast Cancer. 2023-04-14 - 6 citationsThe impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.Elizabeth Terman, Jori Sheade, Fangyuan Zhao, Frederick M Howard, Nora Jaskowiak
Breast Cancer Research and Treatment. 2023-07-01 - 59 citationsClinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.Daniel S Peiffer, Fangyuan Zhao, Nan Chen, Olwen M Hahn, Rita Nanda
JAMA Oncology. 2023-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
